Synaptive Medical Updates its Robotic Microscope With 3D Visualization

Synaptive Medical, a developer of robotic surgical visualization, announced the U.S. and Canadian availability of updates to its flagship surgical technology product, Modus V, a fully automated robotic digital microscope designed to assist surgeons in the operating room for a seamless surgical workflow. The latest product updates strengthen the robotic platform by adding 3D visualization and voice-activated control of the system from the sterile field.
 
Leveraging cutting-edge optical design, Modus V includes high-powered optics and enhanced video processing to provide unobstructed, clear and now three-dimensional views for any surgical approach. The voice-activated control feature augments the existing automation characteristics of the system, including AutoFocus control and hands-free camera positioning using tracked instruments, to eliminate the need for manual adjustments common with conventional visualization tools. Combined with a 4K 3D digital monitor, this system supports a much more ergonomic and effective approach to microsurgery.
 
Cameron Piron, president and co-founder of Synaptive Medical, stated, “These new features unlock the platform’s use for a wide range of cranial and spinal procedures, supporting our commitment to provide surgeons the tools and information they need to deliver less invasive care for their patients.”
 
“Integrating voice control is a modern approach to connecting surgeons with their technologies in a way that allows them to maximize the benefits of the system to provide better surgical treatment,” added Brad Fernald, Synaptive’s director of surgical product management.
 
Synaptive Medical plans to expand access to these new features to select regions globally following this initial release in the U.S. and Canadian markets.
 
The updates follow the first round of a new preferred equity investment, totaling $25 million, announced late last year. The investment was led by Linamar Corporation, which also entered into a manufacturing agreement with Synaptive, and Audible Capital Corp., an existing investor. A mix of both existing and new investors also participated in this round, and as part of the closing approximately $50 million of Synaptive’s debt converted into equity. 
 
The funding will enable Synaptive to further expand the availability of its suite of fully automated and integrated hardware and software products that enhance healthcare providers’ capabilities in diagnostic imaging, as well as surgical planning, navigation and visualization in the neurological and orthopedic spaces. Synaptive’s products have been uniquely designed to optimize workflow and enhance medical decision-making to improve patient outcomes. 
 
“This investment round is a testament to the continued confidence our investors have in Synaptive’s mission in providing state-of-the-art products that enable surgeons and healthcare professionals to provide safer patient-specific care,” Piron said. “Today, millions of patients, each with their own unique neuroanatomy, undergo highly delicate cranial or spinal procedures for neurological disorders or injuries each year. With this financing, we are committed to broadening the availability of our product offering to further enhance patient care in these critical care settings.”   
 
Synaptive’s product offering includes seven primary products, which enable enhanced surgical planning, visualization both before and during surgery, efficient management of information during the clinical workflow and research tools focused on large scale medical imaging and medical informatics AI research. Synaptive’s products are modular and designed for seamless integration both within the Synaptive suite and with other products, so hospitals may purchase Synaptive offerings either individually or together, to best suit their needs.